“Ultraviolet light (whether by natural sunlight or indoor tanning beds) will increase your risk for skin cancer, and simply protecting your skin from UV exposure, including regular use of daily ...
In January, after the DermaSensor became the first artificial intelligence (AI)-enabled device cleared by the US Food and Drug Administration (FDA) to evaluate lesions suggestive of skin cancer, the ...
Dr Geng discusses his research from AAAAI Annual Meeting, which explored the relationship between atopic dermatitis and comorbid atopic conditions.
As part of this partnership, Affidea has implemented Skin Analytics’ DERM, an AI medical device software for the automated analysis of skin lesions. The initial implementation of DERM began in Romania ...
Now that the year is coming to an end, some people are looking in the mirror to reflect on what could be a possible new year’s resolution for 2024. Most people want to start off the new year by ...
Devices used in combination with medical therapy can improve treatment of acne lesions and even help patients see quicker ...
MIAMI--(BUSINESS WIRE)--DermaSensor Inc., a health technology company equipping primary care physicians (PCPs) with a non-invasive device for use in evaluation of suspicious skin lesions, presented a ...
Oncopatch represents a meaningful addition to the treatment landscape for skin cancer…particularly in situations where ...
Although dermatology may not automatically command the respect of other disciplines such as oncology, Drs. Henry Miller and Renata H. Mullen explain why dermatology is one of modern medicine’s most ...
Experience the GentleMax Pro Plus ® Difference Visit Fargo Dermatology and discover the transformative power of GentleMax Pro Plus ®. Whether you’re looking to achieve smoother skin, reduce signs of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results